BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12374861)

  • 1. PI31 is a modulator of proteasome formation and antigen processing.
    Zaiss DM; Standera S; Kloetzel PM; Sijts AJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Interactions of the Proteasome Inhibitor PI31 with Constitutive and Immuno-20S Proteasomes.
    Wang J; Kjellgren A; DeMartino GN
    Biochemistry; 2024 Apr; 63(8):1000-1015. PubMed ID: 38577872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the macrophage proteasome by ethanol impairs MHC class I antigen processing and presentation.
    D'Souza AJ; Desai SD; Rudner XL; Kelly MN; Ruan S; Shellito JE
    PLoS One; 2013; 8(2):e56890. PubMed ID: 23451104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells.
    Li B; Lei Z; Lichty BD; Li D; Zhang GM; Feng ZH; Wan Y; Huang B
    Cancer Immunol Immunother; 2010 Feb; 59(2):313-21. PubMed ID: 19680649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation.
    Groll M; Larionov OV; Huber R; de Meijere A
    Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4576-9. PubMed ID: 16537370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ubiquitin-Proteasome System in Immune Cells.
    Çetin G; Klafack S; Studencka-Turski M; Krüger E; Ebstein F
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33466553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, Dynamics and Function of the 26S Proteasome.
    Mao Y
    Subcell Biochem; 2021; 96():1-151. PubMed ID: 33252727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Conserved Requirement for
    Rathje CC; Randle SJ; Al Rawi S; Skinner BM; Nelson DE; Majumdar A; Johnson EEP; Bacon J; Vlazaki M; Affara NA; Ellis PJ; Laman H
    Front Physiol; 2019; 10():1278. PubMed ID: 31649556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer.
    Morozov AV; Karpov VL
    Front Oncol; 2019; 9():761. PubMed ID: 31456945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteasome regulator PTRE1 contributes to the turnover of SNC1 immune receptor.
    Thulasi Devendrakumar K; Copeland C; Li X
    Mol Plant Pathol; 2019 Nov; 20(11):1566-1573. PubMed ID: 31393057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond.
    Albornoz N; Bustamante H; Soza A; Burgos P
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses.
    Corridoni D; Shiraishi S; Chapman T; Steevels T; Muraro D; Thézénas ML; Prota G; Chen JL; Gileadi U; Ternette N; Cerundolo V; Simmons A
    Front Immunol; 2019; 10():958. PubMed ID: 31114588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin and Parkinson's disease through the looking glass of genetics.
    Walden H; Muqit MM
    Biochem J; 2017 Apr; 474(9):1439-1451. PubMed ID: 28408429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of FBXO7 (PARK15) results in reduced proteasome activity and models a parkinsonism-like phenotype in mice.
    Vingill S; Brockelt D; Lancelin C; Tatenhorst L; Dontcheva G; Preisinger C; Schwedhelm-Domeyer N; Joseph S; Mitkovski M; Goebbels S; Nave KA; Schulz JB; Marquardt T; Lingor P; Stegmüller J
    EMBO J; 2016 Sep; 35(18):2008-25. PubMed ID: 27497298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death.
    Livneh I; Cohen-Kaplan V; Cohen-Rosenzweig C; Avni N; Ciechanover A
    Cell Res; 2016 Aug; 26(8):869-85. PubMed ID: 27444871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal Carcinogenesis, Radiation Quality, and the Ubiquitin-Proteasome Pathway.
    Datta K; Suman S; Kumar S; Fornace AJ
    J Cancer; 2016; 7(2):174-83. PubMed ID: 26819641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux.
    Giuliano S; Cormerais Y; Dufies M; Grépin R; Colosetti P; Belaid A; Parola J; Martin A; Lacas-Gervais S; Mazure NM; Benhida R; Auberger P; Mograbi B; Pagès G
    Autophagy; 2015; 11(10):1891-904. PubMed ID: 26312386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering preferential interactions within supramolecular protein complexes: the proteasome case.
    Fabre B; Lambour T; Garrigues L; Amalric F; Vigneron N; Menneteau T; Stella A; Monsarrat B; Van den Eynde B; Burlet-Schiltz O; Bousquet-Dubouch MP
    Mol Syst Biol; 2015 Jan; 11(1):771. PubMed ID: 25561571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal α7 deletion of the proteasome 20S core particle substitutes for yeast PI31 function.
    Yashiroda H; Toda Y; Otsu S; Takagi K; Mizushima T; Murata S
    Mol Cell Biol; 2015 Jan; 35(1):141-52. PubMed ID: 25332237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome assembly.
    Gu ZC; Enenkel C
    Cell Mol Life Sci; 2014 Dec; 71(24):4729-45. PubMed ID: 25107634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.